Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Priman Pharmaceutical is a specialized pharmaceutical company headquartered in Zibo, Shandong Province, China. The company focuses on the development and large-scale production of high-end generic drugs and complex formulations, with a particular emphasis on ophthalmology and topical drug delivery systems. Their product portfolio includes advanced treatments for glaucoma, dry eye syndrome, and musculoskeletal pain, utilizing technologies such as microemulsions and sustained-release mechanisms. Priman operates modern, GMP-compliant manufacturing facilities and maintains a robust R&D pipeline aimed at addressing unmet medical needs in chronic disease management. The company is recognized for its technical expertise in difficult-to-manufacture dosage forms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 山东普瑞曼药业.